Your Premier Destination for High-Quality Aesthetic Products and Transformative Beauty Solutions
Reviewed against publicly available manufacturer and regulatory information.
Quick Answer: JUVÉDERM VOLUX (Allergan Aesthetics) is a structural hyaluronic acid filler built on VYCROSS technology. It is the first and only HA filler FDA-approved for improving moderate-to-severe loss of jawline definition in adults over 21. Manufacturer-reported duration is up to one year with optimal treatment. Volux and Voluma are often confused: both are VYCROSS structural products placed deep, but Volux is documented for jawline definition while Voluma is documented for cheek, chin, and temple volume. They are not interchangeable — choose by the region and the goal, not by a firmness label.
Jawline definition has become one of the most requested contouring outcomes, and Volux is the product most associated with it. This guide explains what Volux is, what it is approved for, how it differs from Voluma — the comparison practitioners and buyers ask about most — and what clinics consider when stocking a structural filler. It is an educational overview, not an injection-technique tutorial.
What Is JUVÉDERM VOLUX?
Volux is a hyaluronic acid dermal filler from Allergan Aesthetics, an AbbVie company, and part of the Juvéderm collection. It is manufactured using VYCROSS technology — a proprietary approach that blends high- and low-molecular-weight HA and crosslinks the gel with a small amount of BDDE. Volux, designated VYC-25L in the clinical literature, is the most concentrated gel in the VYCROSS range, reported at 25 mg/mL of crosslinked HA with 3 mg/mL of lidocaine premixed for injection comfort.
Within the collection, Volux sits at the structural end: it is designed for deep placement where firm support and definition are the goal.
What Is Volux Approved For?
JUVÉDERM VOLUX is FDA-approved as the first and only HA filler indicated for improvement of moderate-to-severe loss of jawline definition in adults over the age of 21, approved in 2022.
- Indication: moderate-to-severe loss of jawline definition
- Manufacturer-reported duration: up to 1 year with optimal treatment
- Reported outcome: in the pivotal clinical study reported by the manufacturer, improvement in jawline definition was observed in 69.9% (102/146) of subjects at six months
Approved indications, pack format, and labelling differ by market. For the exact specification of the SKU we supply, see the JUVÉDERM VOLUX with Lidocaine product page.
Voluma vs Volux: Choosing a Structural HA Filler
This is the comparison that matters most, because the two are easy to confuse — both are VYCROSS products, both are structural, and both are placed deep. The difference is the region and the job each is documented for.
| Aspect | VOLUX | VOLUMA |
|---|---|---|
| Technology | VYCROSS | VYCROSS |
| Role | Structural definition | Structural volume |
| FDA indication | Moderate-to-severe loss of jawline definition | Cheek volume loss; chin profile; temple hollowing |
| Typical goal | Sharpen and define the jawline contour | Restore mid-face volume, chin profile, temple hollowing |
| Manufacturer-reported duration | Up to 1 year | Up to 2 years (cheek); up to 1 year (chin) |
How to choose: start from the region and the goal, not from a firmness label. If the objective is a defined jawline contour, Volux is the product documented for it. If the objective is restoring lost mid-face volume, chin profile, or temple hollowing, that is Voluma’s documented territory. The chin is the one area where the two conversations meet — Voluma carries the chin-profile indication, while jawline definition belongs to Volux — so the assessment should be explicit about whether the goal is chin projection or jawline contour. For the full picture on the volume product, see our JUVÉDERM VOLUMA guide.
Safety Considerations
Volux is placed deep in a region containing significant vasculature. As with any injectable filler:
- Although uncommon, inadvertent intravascular injection can cause tissue ischemia or necrosis and, in severe cases, visual impairment. Treatment should only be performed by qualified practitioners with detailed anatomical knowledge and an established complication-response protocol.
- HA filler can often be enzymatically degraded with hyaluronidase, although this does not make injection risk-free or guarantee complete reversal of every complication.
- Temporary treatment-site reactions — such as tenderness, swelling, firmness, or bruising — are the commonly reported effects and typically settle on their own.
Injection plane and technique are anatomy- and product-dependent and are determined by the treating practitioner in line with the product’s instructions for use. This guide does not describe entry points, depths, or dosing.
Why Clinics Stock a Jawline-Definition Product
Jawline contouring is a high-demand outcome, and it is a treatment where the product’s structural properties do real work — a softer or mid-robust HA cannot substitute for a product documented for definition, and using the wrong rheology in a contour area tends to produce a flat or short-lived result.
Clinics typically position a jawline-definition product for patients who:
- ✓ want a sharper, more defined jawline contour without surgery
- ✓ present with moderate-to-severe loss of jawline definition rather than a specific line or fold
- ✓ are already being assessed for mid-face or chin work, where the regions interact
Before adding any structural SKU, verify its documented indication and recommended plane, its rheology, the pack format, area-specific duration evidence, and its regulatory status in the destination market — “firm filler” is not one interchangeable category, and Volux and Voluma are documented for different regions.
Frequently Asked Questions
What is Juvéderm Volux used for?
Volux is FDA-approved for improving moderate-to-severe loss of jawline definition in adults over 21. It is a structural HA filler built on VYCROSS technology — the most concentrated gel in the VYCROSS range — placed deep where firm support and contour definition are the goal.
How long does Volux last?
The manufacturer reports results lasting up to one year with optimal treatment. Individual duration varies with the amount placed, tissue characteristics, movement in the area, and metabolism, so this is a manufacturer-reported guide rather than a guarantee.
What is the difference between Volux and Voluma?
Both are VYCROSS structural products placed deep, but they are documented for different regions. Volux is FDA-approved for jawline definition; Voluma is FDA-approved for cheek volume loss, chin profile, and temple hollowing. Volux is about definition of a contour, Voluma about restoring volume. They are not interchangeable — choose by the region and goal, not by firmness.
Is Volux the same as a jawline filler?
Volux is the product most associated with jawline definition, and it is the first and only HA filler with an FDA indication specifically for moderate-to-severe loss of jawline definition. That said, “jawline filler” describes a treatment goal rather than a single product — other structural products may be used in the region depending on the market, the assessment, and their documented use.
How should a clinic decide between Volux and Voluma when both are on the shelf?
Decide by region and treatment role rather than by a general firmness label. If the goal is jawline contour definition, Volux is the SKU documented for it; if the goal is mid-face volume, chin profile, or temple hollowing, that is Voluma’s documented territory. Where chin and jawline goals overlap, the assessment should state explicitly which outcome is being treated. Check each SKU’s approved indication, recommended plane, area-specific duration evidence, and local regulatory status before stocking.
For clinics and wholesale buyers: view JUVÉDERM VOLUX with Lidocaine or browse the Juvéderm collection, and verify each SKU’s documented indication and regulatory status for your market.
Related Guides
Recommended Products
